FDA’s Biotin Interference Guidance Finalized
Executive Summary
The document recommends testing for blood biotin levels as high as 3500 ng/mL, three times the maximum expected clinical concentration.
You may also be interested in...
Guidance Doc Tackles Biotin Interference In IVDs
Biotin is widely used to encourage skin and hair health. But high biotin levels can interfere with diagnostic tests results, leading the US FDA to issue a draft guidance doc on how manufacturers should address the issue.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.
Interview: Theradaptive To Enter Clinical Trial For Spinal Fusion Implant
Theradaptive, which makes a device-biologic combination product to help speed bone healing, recently got authorization to start human trials from the US FDA. Medtech Insight spoke to CEO Luis Alvarez about the company’s past, present and future.